| 臺大學術典藏 |
2022-08-19T00:20:53Z |
Potentiating the Efficacy of Molecular Targeted Therapy for Hepatocellular Carcinoma by Inhibiting the Insulin-Like Growth Factor Pathway
|
Liou J.-Y.; CHIUN HSU; Cheng A.-L.; Lin L.-I.; Lee B.-S.; Chang Y.-C.; Ou D.-L. |
| 臺大學術典藏 |
2022-08-19T00:20:46Z |
H3K9 histone methyltransferase, KMT1E/SETDB1, Cooperates with the SMAD2/3 pathway to suppress lung cancer metastasis
|
Wu P.-C.; Lu J.-W.; Yang J.-Y.; Lin I.-H.; Ou D.-L.; Lin Y.-H.; Chou K.-H.; Huang W.-F.; Wang W.-P.; Huang Y.-L.; CHIUN HSU; Lin L.-I.; Lin Y.-M.; James Shen C.-K.; Tzeng T.-Y. |
| 臺大學術典藏 |
2022-08-19T00:20:43Z |
Cyclin E1 inhibition can overcome sorafenib resistance in hepatocellular carcinoma cells through Mcl-1 suppression
|
Ou D.-L.; Cheng A.-L.; Shao Y.-Y.; Feng Z.-R.; Lin L.-I.; Cheng Y.-C.; CHIUN HSU |
| 臺大學術典藏 |
2022-08-19T00:20:25Z |
Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer
|
Jian C.-Z.; Ou P.-Y.; Ou D.-L.; Hsieh C.-H.; Lin L.-I.; Low G.-S.; CHIUN HSU |
| 臺大學術典藏 |
2022-08-19T00:20:23Z |
Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinoma
|
Shao Y.-Y.; Lin L.-I.; Ling A.; CHIUN HSU; Chen P.-S.; Lee B.-S.; Cheng A.-L.; Ou D.-L. |
| 臺大學術典藏 |
2022-04-25T07:36:14Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Tien F.-M.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; JIA-HAU LIU; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-25T07:36:12Z |
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission
|
Tien F.-M.; Tsai C.-H.; Huang S.-C.; JIA-HAU LIU; Chen C.-Y.; Kuo Y.-Y.; Chuang Y.-K.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Wu Y.-S.; Hou M.-F.; Wu S.-J.; Hsu S.-C.; Ko B.-S.; Chou W.-C.; Yao M.; Hou H.-A.; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-25T03:57:25Z |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
|
Tsai C.-H;Tang J.-L;Tien F.-M;Kuo Y.-Y;Wu D.-C;Lin C.-C;Tseng M.-H;Peng Y.-L;Hou M.-F;Chuang Y.-K;Liu M.-C;Liu C.-W;Yao M;Lin L.-I;Chou W.-C;Chen C.-Y;Hou H.-A;Tien H.-F.; Tsai C.-H; Tang J.-L; Tien F.-M; Kuo Y.-Y; Wu D.-C; Lin C.-C; Tseng M.-H; Peng Y.-L; Hou M.-F; Chuang Y.-K; Liu M.-C; Liu C.-W; Yao M; Lin L.-I; Chou W.-C; Chen C.-Y; Hou H.-A; Tien H.-F.; CHIEN-YU CHEN |
| 臺大學術典藏 |
2022-04-14T07:20:27Z |
Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients
|
FENG-MING TIEN; Hou H.-A.; Tsai C.-H.; Tang J.-L.; Chen C.-Y.; Kuo Y.-Y.; Li C.-C.; Lin C.-T.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-14T07:20:27Z |
GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
|
FENG-MING TIEN; Hou H.-A.; Tsai C.-H.; Tang J.-L.; Chiu Y.-C.; Chen C.-Y.; Kuo Y.-Y.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Lin C.-T.; Wu S.-J.; Ko B.-S.; Hsu S.-C.; Huang S.-Y.; Yao M.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-14T07:20:26Z |
Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients
|
Tsai C.-H.; Yao C.-Y.; FENG-MING TIEN; Tang J.-L.; Kuo Y.-Y.; Chiu Y.-C.; Lin C.-C.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Yao M.; Lin L.-I.; Chou W.-C.; Chen C.-Y.; Hou H.-A.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-14T07:20:26Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
FENG-MING TIEN; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-14T07:20:23Z |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
|
Tsai C.-H.; Tang J.-L.; FENG-MING TIEN; Kuo Y.-Y.; Wu D.-C.; Lin C.-C.; Tseng M.-H.; Peng Y.-L.; Hou M.-F.; Chuang Y.-K.; Liu M.-C.; Liu C.-W.; Yao M.; Lin L.-I.; Chou W.-C.; Chen C.-Y.; Hou H.-A.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-14T07:20:22Z |
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission
|
FENG-MING TIEN; Tsai C.-H.; Huang S.-C.; Liu J.-H.; Chen C.-Y.; Kuo Y.-Y.; Chuang Y.-K.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Wu Y.-S.; Hou M.-F.; Wu S.-J.; Hsu S.-C.; Ko B.-S.; Chou W.-C.; Yao M.; Hou H.-A.; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-12T05:36:57Z |
Association between risk factors, molecular features and CpG island methylator phenotype colorectal cancer among different age groups in a Taiwanese cohort
|
Chen K.-H.; Lin L.-I.; Yuan C.-T.; Tseng L.-H.; Chao Y.-L.; YI-HSIN LIANG; Liang J.-T.; Lin B.-R.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2022-03-10T07:58:45Z |
Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer
|
Lin Y.-L.; Liau J.-Y.; Yu S.-C.; LI-HUI TSENG; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-03-10T07:58:45Z |
KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells
|
Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Ou D.-L.; Lin L.-I.; LI-HUI TSENG; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-03-10T07:58:43Z |
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients
|
Lin Y.-.; Liang Y.-H.; Tsai J.-H.; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; LI-HUI TSENG; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-03-10T07:58:41Z |
Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations
|
Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; LI-HUI TSENG; Lin L.-I.; Chang Y.-L.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2022-03-10T07:58:41Z |
Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression
|
Huang H.-N.; Lin M.-C.; LI-HUI TSENG; Chiang Y.-C.; Lin L.-I.; Lin Y.-F.; Huang H.-Y.; Kuo K.-T. |
| 臺大學術典藏 |
2022-03-10T07:58:41Z |
Aberrant expression of annexin A10 is closely related to gastric phenotype in serrated pathway to colorectal carcinoma
|
Tsai J.-H.; Lin Y.-L.; Cheng Y.-C.; Chen C.-C.; Lin L.-I.; LI-HUI TSENG; Cheng M.-L.; Liau J.-Y.; Jeng Y.-M. |
| 臺大學術典藏 |
2022-03-10T07:58:38Z |
BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer
|
Chen K.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; LI-HUI TSENG; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-03-10T07:58:38Z |
Frequent BRAF mutation in early-onset colorectal cancer in Taiwan: Association with distinct clinicopathological and molecular features and poor clinical outcome
|
Tsai J.-H.; Liau J.-Y.; Lin Y.-L.; LI-HUI TSENG; Lin L.-I.; Yeh K.-H.; Jeng Y.-M. |
| 臺大學術典藏 |
2022-03-10T07:58:36Z |
CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal Cancer
|
Chen K.-H.; Lin L.-I.; LI-HUI TSENG; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2022-03-10T07:58:34Z |
Association between risk factors, molecular features and CpG island methylator phenotype colorectal cancer among different age groups in a Taiwanese cohort
|
Chen K.-H.; Lin L.-I.; Yuan C.-T.; LI-HUI TSENG; Chao Y.-L.; Liang Y.-H.; Liang J.-T.; Lin B.-R.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2022-02-21T02:04:33Z |
Association between risk factors, molecular features and CpG island methylator phenotype colorectal cancer among different age groups in a Taiwanese cohort
|
Chen K.-H.; Lin L.-I.; Yuan C.-T.; Tseng L.-H.; Chao Y.-L.; Liang Y.-H.; Liang J.-T.; Lin B.-R.; ANN-LII CHENG; Yeh K.-H. |
| 臺大學術典藏 |
2022-02-18T08:46:54Z |
Aberrant expression of annexin A10 is closely related to gastric phenotype in serrated pathway to colorectal carcinoma
|
Tsai J.-H.; Lin Y.-L.; Cheng Y.-C.; CHIEN-CHUAN CHEN; Lin L.-I.; Tseng L.-H.; Cheng M.-L.; Liau J.-Y.; Jeng Y.-M. |
| 臺大學術典藏 |
2022-02-18T08:46:51Z |
Traditional serrated adenoma with BRAF mutation is associated with synchronous/metachronous BRAF-mutated serrated lesions
|
Tsai J.-H.; Cheng C.-H.; CHIEN-CHUAN CHEN; Lin Y.-L.; Lin L.-I.; Chen M.-L.; Liau J.-Y. |
| 臺大學術典藏 |
2022-02-08T06:27:21Z |
Repurposing cabozantinib with therapeutic potential in KIT-driven t(8;21) acute myeloid leukaemias
|
Su K.-W.; DA-LIANG OU; Fu Y.-H.; Tien H.-F.; Hou H.-A.; Lin L.-I. |
| 臺大學術典藏 |
2022-02-08T06:27:20Z |
Cabozantinib promotes erythroid differentiation in K562 erythroleukemia cells through global changes in gene expression and JNK activation
|
Fu Y.-H.; DA-LIANG OU; Yang Y.-R.; Su K.-W.; Chen C.-Y.; Tien H.-F.; Lai Z.-S.; Shen C.-K.J.; Chien H.-F.; Lin L.-I. |
| 臺大學術典藏 |
2022-02-08T06:27:18Z |
Deciphering the role of pyrvinium pamoate in the generation of integrated stress response and modulation of mitochondrial function in myeloid leukemia cells through transcriptome analysis
|
Fu Y.-H.; Tseng C.-Y.; Lu J.-W.; Lu W.-H.; Lan P.-Q.; Chen C.-Y.; DA-LIANG OU; Lin L.-I. |
| 臺大學術典藏 |
2022-02-08T06:27:17Z |
Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer
|
Hsieh C.-H.; Jian C.-Z.; Lin L.-I.; Low G.-S.; Ou P.-Y.; Hsu C.; DA-LIANG OU |
| 臺大學術典藏 |
2022-01-24T06:05:32Z |
Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer
|
Hsieh C.-H.; Jian C.-Z.; Lin L.-I.; Low G.-S.; Ou P.-Y.; CHIUN HSU; Ou D.-L. |
| 臺大學術典藏 |
2022-01-12T07:07:46Z |
Characterization of acute myeloid leukemia with PTPN11 mutation: The mutation is closely associated with NPM1 mutation but inversely related to FLT3/ITD
|
HSIN-AN HOU; Chou W.-C.; Lin L.-I.; Chen C.-Y.; Tang J.-L.; Tseng M.-H.; Huang C.-F.; Chiou R.-J.; Lee F.-Y.; Liu M.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:46Z |
Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia
|
HSIN-AN HOU; Chou W.-C.; Lin L.-I.; Tang J.-L.; Tseng M.-H.; Huang C.-F.; Yao M.; Chen C.-Y.; Tsay W.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:45Z |
Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: Comparative analysis of 493 adult patients
|
Chou W.-C.; Chen C.-Y.; HSIN-AN HOU; Lin L.-I.; Tang J.-L.; Yao M.; Tsay W.; Ko B.-S.; Wu S.-J.; Huang S.-Y.; Hsu S.-C.; Chen Y.-C.; Huang Y.-N.; Tseng M.-H.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:45Z |
Marrow osteopontin level as a prognostic factor in acute myeloid leukaemia
|
Lee C.-Y.; Tien H.-F.; HSIN-AN HOU; Chou W.-C.; Lin L.-I. |
| 臺大學術典藏 |
2022-01-12T07:07:44Z |
AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: Prognostic implication and interaction with other gene alterations
|
Tang J.-L.; HSIN-AN HOU; Chen C.-Y.; Liu C.-Y.; Chou W.-C.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Lin L.-I.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:44Z |
Reply to Heterogeneity within AML with CEBPA mutations; Only CEBPA double mutations, but not single CEBPA mutations are associated with favorable prognosis
|
HSIN-AN HOU; Lin L.-I.; Chen C.-Y.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:42Z |
WT1 mutation in 470 adult patients with acute myeloid leukemia: Stability during disease evolution and implication of its incorporation into a survival scoring system
|
HSIN-AN HOU; Huang T.-C.; Lin L.-I.; Liu C.-Y.; Chen C.-Y.; Chou W.-C.; Tang J.-L.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:41Z |
CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia
|
Lin T.-C.; HSIN-AN HOU; Chou W.-C.; Ou D.-L.; Yu S.-L.; Tien H.-F.; Lin L.-I. |
| 臺大學術典藏 |
2022-01-12T07:07:40Z |
Sensitive measurement of quantity dynamics of FLT3 internal tandem duplication at early time points provides prognostic information
|
Chou W.-C.; HSIN-AN HOU; Liu C.-Y.; Chen C.-Y.; Lin L.-I.; Huang Y.-N.; Chao Y.-C.; Hsu C.-A.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:40Z |
Rapid assessment of the heterogeneous methylation status of CEBPA in patients with acute myeloid leukemia by using high-resolution melting profile
|
Lin T.-C.; Jiang S.-S.; Chou W.-C.; HSIN-AN HOU; Lin Y.-M.; Chang C.-L.; Hsu C.-A.; Tien H.-F.; Lin L.-I. |
| 臺大學術典藏 |
2022-01-12T07:07:37Z |
DNMT3A mutations in acute myeloid leukemia: Stability during disease evolution and clinical implications
|
HSIN-AN HOU; Kuo Y.-Y.; Liu C.-Y.; Chou W.-C.; Lee M.C.; Chen C.-Y.; Lin L.-I.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:35Z |
Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia
|
HSIN-AN HOU; Lin C.-C.; Chou W.-C.; Liu C.-Y.; Chen C.-Y.; Tang J.-L.; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Kuo Y.-Y.; Lee M.-C.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:34Z |
MicroRNA let-7a-3 gene methylation is associated with karyotyping, CEBPA promoter methylation, and survival in acute myeloid leukemia
|
Ko Y.-C.; Fang W.-H.; Lin T.-C.; HSIN-AN HOU; Chen C.-Y.; Tien H.-F.; Lin L.-I. |
| 臺大學術典藏 |
2022-01-12T07:07:29Z |
TP53 mutations in de novo acute myeloid leukemia patients: Longitudinal follow-ups show the mutation is stable during disease evolution
|
HSIN-AN HOU; Chou W.-C.; Kuo Y.-Y.; Liu C.-Y.; Lin L.-I.; Tseng M.-H.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Chen C.-Y.; Lin C.-T.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:28Z |
GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution
|
HSIN-AN HOU; Lin Y.-C.; Kuo Y.-Y.; Chou W.-C.; Lin C.-C.; Liu C.-Y.; Chen C.-Y.; Lin L.-I.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:27Z |
Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia
|
HSIN-AN HOU; Liu C.-Y.; Kuo Y.-Y.; Chou W.-C.; Tsai C.-H.; Lin C.-C.; Lin L.-I.; Tseng M.-H.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Li C.-C.; Huang S.Y.; Ko B.-S.; Hsu S.-C.; Chen C.-Y.; Lin C.-T.; Wu S.-J.; Tsay W.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:25Z |
Genetic alterations and their clinical implications in older patients with acute myeloid leukemia
|
Tsai C.-H.; HSIN-AN HOU; Tang J.-L.; Liu C.-Y.; Lin C.-C.; Chou W.-C.; Tseng M.-H.; Chiang Y.-C.; Kuo Y.-Y.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Tsay W.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Chen C.-Y.; Lin C.-T.; Wu S.-J.; Tien H.-F. |
